Picture of Co-Diagnostics logo

CODX — Co-Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview

* Co-Diagnostics Inc  CODX.OQ   CODX.O  is expected to show
a fall
in quarterly revenue when it reports  results on August 10. 
    * The Salt Lake City Utah-based  company is expected to
report  a
90.0% decrease in revenue to $500 thousand from $5.02 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Co-Diagnostics Inc
is for
a loss of 24 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $3.5​, above​ its last closing price of $1.37. ​​​

This summary was machine generated August 9 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Co-Diagnostics

See all news